IATDMCT 2017

Presentation information

Print

Poster

[P25-7] P25-7: Immunosuppressive drugs (2): Monoclonal antibody and genotyping

Mon. Sep 25, 2017 12:30 PM - 1:30 PM Annex Hall (1F)

Chair: Toru Hashida, Japan

[P25-7-5] Assay development toward Infliximab therapeutic monitoring by LCMS: new strategy using CDR-peptide selective proteolysis nSMOL

Takashi Shimada1, Noriko Iwamoto2, Atsushi Yonezawa3, Kazuo Matsubara4 (1.Shimadzu Corporation, 2.Shimadzu Corporation, 3.Kyoto University, 4.Kyoto University Hospital)

Keywords:Infliximab, Antibody drug, nSMOL, LCMS, Bioanalysis

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Password